Lung Cancer Trials Ask AI to find trials
UnknownNot applicableNCT05171491
Official study title

LungLB in Subjects Presenting With Indeterminate Pulmonary Nodules

Study summary

Correlate performance of LungLB Test with outcome of a scheduled biopsy.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedNot specified

The study team can explain what participation involves.

Who it may be forSolitary Pulmonary Nodule · Multiple Pulmonary Nodules

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jun 13, 2024 · Source: ClinicalTrials.gov

Is enrollment open?Unknown

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?12 U.S. locations

Locations may change over time.

Who runs it?LungLife AI

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
LungLife AI
Interventions being studied
Not specified
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

1. At least 18 years old with a CT identified indeterminate pulmonary nodule and scheduled for biopsy, at the time of consent. 2. Planned biopsy nodule of interest: 1. is solid ≤3 cm; or 2. is nonsolid, ground glass opacity, of any size; or 3. is part solid, where the solid component is no larger than 3cm (maximum diameter).

Reasons someone may not be able to joinExclusion criteria

1. Current and or prior diagnosis +/- treatment of non-lung cancer within the past 3 years. 2. Current and or prior lung cancer diagnosis within 2 years following intent-to-cure surgery.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Clinical Site 04Los Angeles, California
  • Clinical Site 05Bay Pines, Florida
  • Clinical Site 03Miami, Florida
  • Clinical Site 07Hines, Illinois
  • Clinical Site 27Kansas City, Kansas
  • Clinical Site 12Wichita, Kansas
  • Clinical Site 08Kansas City, Missouri
  • Clinical Site 18Reno, Nevada
  • Clinical Site 01New York, New York
  • Clinical Site 25Columbia, South Carolina
  • Clinical Site 02Houston, Texas
  • Clinical Site 32Milwaukee, Wisconsin

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 13, 2024. Always confirm current availability with the study team.

View original record ↗